| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 152, 1591-1598, Copyright © 1998 by American Society for Investigative Pathology
REGULAR ARTICLES |
PS Larson, A de las Morenas, LA Cupples, K Huang and CL Rosenberg
Cancer Research Center, Boston University School of Medicine, Massachusetts 02118, USA.
Breast cancer is believed to develop as multiple genetic abnormalities accumulate, each conferring some growth advantage, but the timing and nature of the earliest steps in this progression are not yet elucidated. Proliferative breast lesions, associated with an increased risk of breast cancer although considered benign, recently were shown to contain clonal genetic abnormalities. Therefore, we hypothesized that clonal genetic abnormalities might be detectable before any phenotypic abnormalities are evident, ie, in histologically normal breast tissue. We examined DNA extracted from 95 normal-appearing breast ducts or terminal ductal-lobular units from 20 individuals at varying degrees of risk (those undergoing reduction mammoplasties, those with atypical hyperplastic proliferative lesions, and those already diagnosed with breast cancer). Using nine microsatellite markers, we sought evidence of genetic instability or of allelic imbalance (most likely representing loss of heterozygosity). We found genetically abnormal clones in 21/95 (22%) seemingly normal samples from 10/20 (50%) women from all three risk groups. In women under age 50, trends toward increased rates of abnormalities were noted with increased cancer risk. The abnormalities identified were more likely to be at sites of known or postulated tumor suppressor genes rather than at random or neutral loci. Our data indicate that genetic abnormalities potentially critical to breast tumorigenesis accumulate before pathological detection even of high-risk lesions and are detectable in tissue that is not only histologically benign but also completely normal.
This article has been cited by other articles:
 |
|
 |
|
  H. Rubin Cell-cell contact interactions conditionally determine suppression and selection of the neoplastic phenotype PNAS, April 29, 2008; 105(17): 6215 - 6221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Yan, C. Venkataramu, A. Ibrahim, J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y.-W. Leu, C. L. Shapiro, et al. Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue. Clin. Cancer Res., November 15, 2006; 12(22): 6626 - 6636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Larson, B. L. Schlechter, A. de las Morenas, J. E. Garber, L. A. Cupples, and C. L. Rosenberg Allele Imbalance, or Loss of Heterozygosity, in Normal Breast Epithelium of Sporadic Breast Cancer Cases and BRCA1 Gene Mutation Carriers Is Increased Compared With Reduction Mammoplasty Tissues J. Clin. Oncol., December 1, 2005; 23(34): 8613 - 8619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Ellsworth, R. E. Ellsworth, B. Love, B. Deyarmin, S. M. Lubert, V. Mittal, J. A. Hooke, and C. D. Shriver Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability Ann. Surg. Oncol., September 1, 2004; 11(9): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. Schlechter, Q. Yang, P. S. Larson, A. Golubeva, R. A. Blanchard, A. de Las Morenas, and C. L. Rosenberg Quantitative DNA Fingerprinting May Distinguish New Primary Breast Cancer From Disease Recurrence J. Clin. Oncol., May 15, 2004; 22(10): 1830 - 1838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. M. Braakhuis, M. P. Tabor, J. A. Kummer, C. R. Leemans, and R. H. Brakenhoff A Genetic Explanation of Slaughter's Concept of Field Cancerization: Evidence and Clinical Implications Cancer Res., April 15, 2003; 63(8): 1727 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Holst, G. J. Nuovo, M. Esteller, K. Chew, S. B. Baylin, J. G. Herman, and T. D. Tlsty Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia Cancer Res., April 1, 2003; 63(7): 1596 - 1601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Franco, L. Arnould, F. Mege, S.-F. Picard, P. Arveux, and S. Lizard-Nacol Comparative Analysis of Molecular Alterations in Fibroadenomas Associated or Not With Breast Cancer Arch Surg, March 1, 2003; 138(3): 291 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Larson, A. de las Morenas, S. R. Bennett, L. A. Cupples, and C. L. Rosenberg Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas Am. J. Pathol., July 1, 2002; 161(1): 283 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Rodins, M. Cheale, N. Coleman, and S. B. Fox Minichromosome Maintenance Protein 2 Expression in Normal Kidney and Renal Cell Carcinomas: Relationship to Tumor Dormancy and Potential Clinical Utility Clin. Cancer Res., April 1, 2002; 8(4): 1075 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Scott, R. Bendix, P. Chen, R. Clark, T. Dork, and M. F. Lavin Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer PNAS, January 22, 2002; 99(2): 925 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Franco, S.-F. Picard, F. Mege, L. Arnould, and S. Lizard-Nacol Absence of Genetic Abnormalities in Fibroadenomas of the Breast Determined at p53 Gene Mutations and Microsatellite Alterations Cancer Res., November 1, 2001; 61(21): 7955 - 7958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Rubin Selected Cell and Selective Microenvironment in Neoplastic Development Cancer Res., February 1, 2001; 61(3): 799 - 807. [Abstract] [Full Text]
|
|
|
|
|
|
M. Chow and H. Rubin Clonal Selection versus Genetic Instability as the Driving Force in Neoplastic Transformation Cancer Res., November 1, 2000; 60(22): 6510 - 6518. [Abstract] [Full Text]
|
|
|
|
|
|
A. S. C. Chan, K. F. To, K. W. Lo, K. F. Mak, W. Pak, B. Chiu, G. M. K. Tse, M. Ding, X. Li, J. C. K. Lee, et al. High Frequency of Chromosome 3p Deletion in Histologically Normal Nasopharyngeal Epithelia from Southern Chinese Cancer Res., October 1, 2000; 60(19): 5365 - 5370. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Dunn, J. Garde, K. Dolan, J. R. Gosney, B. C. Oates, A. J. M. Watson, P. Fielding, and J. K. Field The Evolution of Loss of Heterozygosity on Chromosome 17 during the Progression to Barrett's Adenocarcinoma Involves a Unique Combination of Target Sites in Individual Specimens Clin. Cancer Res., October 1, 2000; 6(10): 4033 - 4042. [Abstract] [Full Text]
|
|
|
|
|
|
C. Washington, F. Dalbegue, F. Abreo, J. K. Taubenberger, and J. H. Lichy Loss of Heterozygosity in Fibrocystic Change of the Breast : Genetic Relationship Between Benign Proliferative Lesions and Associated Carcinomas Am. J. Pathol., July 1, 2000; 157(1): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Kopelovich, D. E. Henson, A. F. Gazdar, B. Dunn, S. Srivastava, G. J. Kelloff, and P. Greenwald Surrogate Anatomic/Functional Sites for Evaluating Cancer Risk: An Extension of the Field Effect Clin. Cancer Res., December 1, 1999; 5(12): 3899 - 3905. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
